Approval · Notice of Compliance 25587 · 2021
ALVESCO: Notice of Compliance 25587
Issued March 31, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 25587
- Date
- March 31, 2021
- Company
- Covis Pharma GmbhZug, Zug, Switzerland
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
Products in this notice
Medicinal ingredients
- CICLESONIDE 100 MCG per ACT
- CICLESONIDE 200 MCG per ACT